Search research articles
Contact Us
Filters
Showing results (41-50 of 187) with videos related to
Page
of 19
Sort By:
Journal of the Society for Gynecologic Investigation
|
January 5, 2005
An interleukin-6 gene promoter polymorphism and unexplained late intrauterine fetal death: a multicenter study
Ambros Huber, Christoph Grimm, Stefan Jirecek, et al.
Metal-Based Drugs
|
July 10, 2009
In Vitro Evaluation of Oxoplatin: An Oral Platinum(IV) Anticancer Agent
Ulrike Olszewski, Florian Ach, Ernst Ulsperger, et al.
BMC Cancer
|
April 11, 2009
KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay
Veronika Auner, Gernot Kriegshäuser, Dan Tong, et al.
Investigational New Drugs
|
October 1, 2021
Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung Cancer
Adelina Plangger, Barbara Rath, Maximilian Hochmair, et al.
Journal of the Society for Gynecologic Investigation
|
October 18, 2002
Tumor necrosis factor-alpha promotor polymorphisms and endometriosis
Fritz Wieser, Gerhild Fabjani, Clemens Tempfer, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
June 5, 2007
The prohibitin 3' untranslated region polymorphism in patients with ovarian cancer
Christoph Grimm, Stephan Polterauer, Robert Zeillinger, et al.
Investigational New Drugs
|
February 18, 2010
Anticancer activity and mode of action of titanocene C
Ulrike Olszewski, James Claffey, Megan Hogan, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
January 2, 2007
The lack of laminin-5 as a prognostic marker in low-grade cervical squamous intraepithelial lesions: correlation with clinical follow-up data
Barbara Tringler, Christoph Grimm, Grazyna Dudek, et al.
Oncology Reports
|
February 12, 2005
Identification of L1CAM, Jagged2 and Neuromedin U as ovarian cancer-associated antigens
Nicole I Euer, Sepp Kaul, Helmut Deissler, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
December 16, 2015
Association of HER2 codon 655 polymorphism with ovarian cancer
Rafał Watrowski, Dan Cacsire Castillo-Tong, Eva Schuster, et al.
Page
of 19
Search research articles
Search
Showing results (41-50 of 187) with videos related to
Sort By:
Page
of 19
Journal of the Society for Gynecologic Investigation
|
January 5, 2005
An interleukin-6 gene promoter polymorphism and unexplained late intrauterine fetal death: a multicenter study
Ambros Huber, Christoph Grimm, Stefan Jirecek, et al.
Metal-Based Drugs
|
July 10, 2009
In Vitro Evaluation of Oxoplatin: An Oral Platinum(IV) Anticancer Agent
Ulrike Olszewski, Florian Ach, Ernst Ulsperger, et al.
BMC Cancer
|
April 11, 2009
KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay
Veronika Auner, Gernot Kriegshäuser, Dan Tong, et al.
Investigational New Drugs
|
October 1, 2021
Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung Cancer
Adelina Plangger, Barbara Rath, Maximilian Hochmair, et al.
Journal of the Society for Gynecologic Investigation
|
October 18, 2002
Tumor necrosis factor-alpha promotor polymorphisms and endometriosis
Fritz Wieser, Gerhild Fabjani, Clemens Tempfer, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
June 5, 2007
The prohibitin 3' untranslated region polymorphism in patients with ovarian cancer
Christoph Grimm, Stephan Polterauer, Robert Zeillinger, et al.
Investigational New Drugs
|
February 18, 2010
Anticancer activity and mode of action of titanocene C
Ulrike Olszewski, James Claffey, Megan Hogan, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
January 2, 2007
The lack of laminin-5 as a prognostic marker in low-grade cervical squamous intraepithelial lesions: correlation with clinical follow-up data
Barbara Tringler, Christoph Grimm, Grazyna Dudek, et al.
Oncology Reports
|
February 12, 2005
Identification of L1CAM, Jagged2 and Neuromedin U as ovarian cancer-associated antigens
Nicole I Euer, Sepp Kaul, Helmut Deissler, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
December 16, 2015
Association of HER2 codon 655 polymorphism with ovarian cancer
Rafał Watrowski, Dan Cacsire Castillo-Tong, Eva Schuster, et al.
Page
of 19